DS
SANA icon

DRW Securities’s Sana Biotechnology SANA Stock Holding History

DRW Securities’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.7K Buy
+12,383
New +$48.8K ﹤0.01% 1209

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

DRW Securities's SANA Position: Q1 2026 in Review

DRW Securities opened a new position in Sana Biotechnology (SANA) in Q1 2026: 12,383 shares worth $35.7K. The stake represents ﹤0.01% of the portfolio and ranks #1209 among its holdings.

202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • DRW Securities held 12,383 shares of Sana Biotechnology worth $35.7K as of Q1 2026.
  • Sana Biotechnology was a new DRW Securities position in Q1 2026.
  • Sana Biotechnology made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #1209 holding.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.